Global Health Limited (MEDANTA.BO)
BSE · INR · Healthcare · Medical Care Facilities
₹1,260.00 (+4.29%) as of
Key statistics
- Market cap
- 338.38B
- P/E (TTM)
- 60.93
- Forward P/E
- 37.51
- EPS (TTM)
- 20.68
- Dividend yield
- 0.04%
- 52-week range
- 955.20 – 1,542.00
- Beta
- 0.16
- Revenue (TTM)
- 46.83B
- Profit margin
- 11.87%
- Analyst target
- ₹1,599.05
- Volume
- 63.17k
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, lab and pathology, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinions, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup services. In addition, the company is involved in trading pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Gurugram, India
- Employees
- 12,600
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.